Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide

Glioblastoma multiforme (GBM) is the most aggressive type of human primary brain tumor. The standard treatment protocol includes radiotherapy in combination with temozolomide (TMZ). Despite advances in GBM treatment, the survival time of patients diagnosed with glioma is 14.5 months. Regarding tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sales, Thais Torquato, Resende, Fernando Francisco Borges, Chaves, Natália Lemos, Titze-De-Almeida, Simoneide Souza, Báo, Sônia Nair, Brettas, Marcella Lemos, Titze-De-Almeida, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038559/
https://www.ncbi.nlm.nih.gov/pubmed/27698831
http://dx.doi.org/10.3892/ol.2016.4992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038559/
https://www.ncbi.nlm.nih.gov/pubmed/27698831
http://dx.doi.org/10.3892/ol.2016.4992

Ejemplares similares